Advertisement

Acta Neurochirurgica

, Volume 160, Issue 4, pp 811–821 | Cite as

Selective dorsal rhizotomy for the treatment of severe spastic cerebral palsy: efficacy and therapeutic durability in GMFCS grade IV and V children

  • Daniel D’Aquino
  • Ahmad A. Moussa
  • Amr Ammar
  • Harshal Ingale
  • Michael Vloeberghs
Original Article - Functional

Abstract

Background

Selective dorsal rhizotomy (SDR) has been established as an effective surgical treatment for spastic diplegia. The applicability of SDR to the full spectrum of spastic cerebral palsy and the durability of its therapeutic effects remain under investigation. There are currently limited data in the literature regarding efficacy and outcomes following SDR in Gross Motor Function Classification System (GMFCS) IV and V patients. Intrathecal baclofen has traditionally been the surgical treatment of choice for these patients. When utilised primarily as a treatment for the relief of spasticity, it is proposed that SDR represents a rational and effective treatment option for this patient group. We report our outcomes of SDR performed on children with severe cerebral palsy (GMFCS grade IV and V). The commensurate improvement in upper as well as lower limb spasticity is highlighted. Apparent benefit to urological function following SDR in this patient group is also discussed.

Method

A retrospective review of prospectively collected data for 54 paediatric patients with severe cerebral palsy (GMFCS IV-V) who received SDR plus specialised physiotherapy. Mean age was 10.2 years (range, 3.0–19.5). SDR guided by electrophysiological monitoring was performed by a single experienced neurosurgeon. All subjects received equivalent physiotherapy. The primary outcome measure was change to the degree of spasticity following SDR. Spasticity of upper and lower limb muscle groups were quantified and standardised using the Ashworth score. Measures were collected at baseline and at 2-, 8- and 14-month postoperative intervals. In addition, baseline and 6-month postoperative urological function was also evaluated as a secondary outcome measure.

Results

The mean lower limb Ashworth score at baseline was 3.2 (range, 0–4). Following SDR, significant reduction in lower limb spasticity scores was observed at 2 months and maintained at 8 and 14 months postoperatively (Wilcoxon rank, p < 0.001). The mean reduction at 2, 8 and 14 months was 3.0, 3.2 and 3.2 points respectively (range, 1–4), confirming a sustained improvement of spasticity over a 1-year period of follow-up. Significant reduction in upper limb spasticity scores following SDR was also observed (mean, 2.9; Wilcoxon rank, p < 0.001). Overall, the improvement to upper and lower limb tone following SDR—generally to post-treatment Ashworth scores of 0—was clinically and statistically significant in GMFCS IV and V patients. Urological assessment identified pre-existing bladder dysfunction in 70% and 90% of GMFCS IV and V patients respectively. Following SDR, improvement in urinary continence was observed in 71% of affected GMFCS IV and 42.8% of GMFCS V patients. No serious postoperative complications were identified.

Conclusions

We conclude that SDR is safe and—in combination with physiotherapy—effectively reduces spasticity in GMFCS grade IV and V patients. Our series suggests that spastic quadriplegia is effectively managed with significant improvements in upper limb spasticity that are commensurate with those observed in lower limb muscle groups. These gains are furthermore sustained more than a year postoperatively. In light of these findings, we propose that SDR constitutes an effective treatment option for GMFCS IV and V patients and a rational alternative to intrathecal baclofen.

Keywords

Functional Movement disorder Selective dorsal rhizotomy Spasticity Non-ambulant GMFCS Intrathecal baclofen Paediatric 

Notes

Funding

No funding was received for this research.

Compliance with ethical standards

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study formal consent is not required. Institutional review board approval for notes review was obtained from Nottingham University Hospitals NHS Trust.

References

  1. 1.
    Abbott R, Johann-Murphy M, Shiminski-Maher T, Quartermain D, Forem SL, Gold JT et al (1993) Selective dorsal rhizotomy: outcome and complications in treating spastic cerebral palsy. Neurosurgery 33:851–857PubMedGoogle Scholar
  2. 2.
    Ailon T, Beauchamp R, Miller S, Mortenson P, Kerr JM, Hengel AR, Steinbok P (2015) Long-term outcome after selective dorsal rhizotomy in children with spastic cerebral palsy. Childs Nerv Syst 31(3):415–423CrossRefPubMedGoogle Scholar
  3. 3.
    Albright AL, Barry MJ, Fasick MP, Janosky J (1995) Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity. Pediatr Neurosurg 23:82–85CrossRefPubMedGoogle Scholar
  4. 4.
    Aquilina K, Graham D, Wimalasundera N (2015) Selective dorsal rhizotomy: an old treatment re-emerging. Arch Dis Child 100:798–802CrossRefPubMedGoogle Scholar
  5. 5.
    Bolster EA, van Schie PE, Becher JG et al (2013) Long-term effect of selective dorsal rhizotomy on gross motor function in ambulant children with spastic bilateral cerebral palsy, compared with reference centiles. Dev Med Child Neurol 55:610–616CrossRefPubMedGoogle Scholar
  6. 6.
    Bonica JJ (1990) Neurolytic blockade and hypophysectomy. In: Bonica JJ (ed) The management of pain, 2nd edn. Lea and Febiger, London, pp 1980–1983Google Scholar
  7. 7.
    Chiu PK, Yam KY, Lam TY, Cheng CH, Yu C, Li ML, Chu PS, Man CW (2014) Does selective dorsal rhizotomy improve bladder function in children with cerebral palsy? Int Urol Nephrol 46(10):1929–1933CrossRefPubMedGoogle Scholar
  8. 8.
    Cole GF, Farmer SE, Roberts A et al (2007) Selective dorsal rhizotomy for children with cerebral palsy: the Oswestry experience. Arch Dis Child 92:781–785CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Dudley RW, Parolin M, Gagnon B, Saluja R, Yap R, Montpetit K et al (2013) Long-term functional benefits of selective dorsal rhizotomy for spastic cerebral palsy. Pediatr Neurosurg 12(2):142–150CrossRefGoogle Scholar
  10. 10.
    Farmer JP, Sabbagh AJ (2007) Selective dorsal rhizotomies in the treatment of spasticity related to cerebral palsy. Childs Nerv Syst 23:991CrossRefPubMedGoogle Scholar
  11. 11.
    Fasano VA, Broggi G, Barolat-Romana G, Sguazzi A (1978) Surgical treatment of spasticity in cerebral palsy. Childs Brain 4:289–305PubMedGoogle Scholar
  12. 12.
    Fasano VA, Broggi G, Zeme S, Lo Russo G, Sguazzi A (1980) Long-term results of posterior functional rhizotomy. Acta Neurochir 30:435–439CrossRefGoogle Scholar
  13. 13.
    Fjelstad AB, Hommelstad J, Sorteberg A (2009) Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr 4:487–493CrossRefPubMedGoogle Scholar
  14. 14.
    Gigante P, McDowell MM, Bruce SS, Chirelstein G, Chiriboga CA, Dutkowsky J, Fontana E, Hyman J et al (2013) Reduction in upper-extremity tone after lumbar selective dorsal rhizotomy in children with spastic cerebral palsy. J Neurosurg Pediatr 12(6):588–594CrossRefPubMedGoogle Scholar
  15. 15.
    Golan JD, Hall JA, O’Gorman G et al (2007) Spinal deformities following selective dorsal rhizotomy. J Neurosurg 106:441–449PubMedGoogle Scholar
  16. 16.
    Grunt S, Becher JG, Vermeulen RJ (2011) Long-term outcome and adverse effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review. Dev Med Child Neurol 53:490–498CrossRefPubMedGoogle Scholar
  17. 17.
    Hanna SE, Rosenbaum PL, Bartlett DJ et al (2009) Stability and decline in gross motor function among children and youth with cerebral palsy aged 2 to 21 years. Dev Med Child Neurol 51:295–302CrossRefPubMedGoogle Scholar
  18. 18.
    Heim RC, Park TS, Vogler GP, Kaufman BA, Noetzel MJ, Ortman MR (1995) Changes in hip migration after selective dorsal rhizotomy for spastic quadriplegia in cerebral palsy. J Neurosurg 82:567–571CrossRefPubMedGoogle Scholar
  19. 19.
    Houle AM, Vernet O, Jednak R, Pippi Salle JL, Farmer JP (1998) Bladder function before and after selective dorsal rhizotomy in children with cerebral palsy. J Urol 160(3 Pt 2):1088–1091CrossRefPubMedGoogle Scholar
  20. 20.
    Ingale H, Ughratdar I, Muquit S et al (2016) Selective dorsal rhizotomy as an alternative to intrathecal baclofen pump replacement in GMFCS grades 4 and 5 children. Childs Nerv Syst 32:321–325CrossRefPubMedGoogle Scholar
  21. 21.
    Jarrett L, Nandi P, Thompson AJ (2002) Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role? J Neurol Neurosurg Psychiatry 73:705–709CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Johnson MB, Goldstein L, Thomas SS, Piatt J, Aiona M, Sussman M (2004) Spinal deformity after selective dorsal rhizotomy in ambulatory patients with cerebral palsy. J Pediatr Orthop 24:529–536CrossRefPubMedGoogle Scholar
  23. 23.
    Josenby AL, Wagner P, Jarnlo GB, Westbom L, Nordmark E (2012) Motor function after selective dorsal rhizotomy: a 10-year practice-based follow-up study. Dev Med Child Neurol 54(5):429–435CrossRefPubMedGoogle Scholar
  24. 24.
    Josenby AL, Wagner P, Jarnlo GB, Westbom L, Nordmark E (2015) Functional performance in self-care and mobility after selective dorsal rhizotomy: a 10-year practice-based follow-up study. Dev Med Child Neurol 57(3):286–293CrossRefPubMedGoogle Scholar
  25. 25.
    Kan P, Gooch J, Amini A, Ploeger D, Grams B, Oberg W et al (2008) Surgical treatment of spasticity in children: comparison of selective dorsal rhizotomy and intrathecal baclofen pump implantation. Childs Nerv Syst 24(2):239–243CrossRefPubMedGoogle Scholar
  26. 26.
    Kim DS, Choi JU, Yang KH, Park CI (2001) Selective posterior rhizotomy in children with cerebral palsy: a 10-year experience. Childs Nerv Syst 17:556–562CrossRefPubMedGoogle Scholar
  27. 27.
    Kim HS, Steinbok P, Wickenheiser D (2006) Predictors of poor outcome after selective dorsal rhizotomy in treatment of spastic cerebral palsy. Childs Nerv Syst 22:60–66CrossRefPubMedGoogle Scholar
  28. 28.
    Langerak NG, Lamberts RP, Fieggen AG et al (2008) A prospective gait analysis study in patients with diplegic cerebral palsy 20 years after selective dorsal rhizotomy. J Neurosurg Pediatr 1:180–186CrossRefPubMedGoogle Scholar
  29. 29.
    Langerak NG, Vaughan CL, Hoffman EB, Figaji AA, Fieggen AG, Peter JC (2009) Incidence of spinal abnormalities in patients with spastic diplegia 17 to 26 years after selective dorsal rhizotomy. Childs Nerv Syst 25:1593–1603CrossRefPubMedGoogle Scholar
  30. 30.
    Mäenpää H, Salokorpi T, Jaakkola R et al (2003) Follow-up of children with cerebral palsy after selective posterior rhizotomy with intensive physiotherapy or physiotherapy alone. Neuropediatrics 34:67–71CrossRefPubMedGoogle Scholar
  31. 31.
    McLaughlin JF, Bjornson KF, Astley SJ, Hays RM, Hoffinger SA, Armantrout EA et al (1994) The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series. Dev Med Child Neurol 36:755–769CrossRefPubMedGoogle Scholar
  32. 32.
    McLaughlin JF, Bjornson KF, Astley SJ, Graubert C, Hays RM, Roberts TS, Price R, Temkin N (1998) Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol 40:220–232CrossRefPubMedGoogle Scholar
  33. 33.
    McLaughlin J, Bjornson K, Temkin N, Steinbok P, Wright V, Reiner A et al (2002) Selective dorsal rhizotomy: metaanalysis of three randomized controlled trials. Dev Med Child Neurol 44:17–25CrossRefPubMedGoogle Scholar
  34. 34.
    Mittal S, Farmer JP, Al-Atassi B, Montpetit K, Gervais N, Poulin C, Benaroch TE, Cantin ME (2002) Functional performance following selective posterior rhizotomy: long-term results determine using a validated evaluative measure. J Neurosurg 97:510–518CrossRefPubMedGoogle Scholar
  35. 35.
    Motta F, Antonello CE (2014) Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr 13:301–306CrossRefPubMedGoogle Scholar
  36. 36.
    Nathan PW (1969) Treatment of spasticity with perineural injections of phenol. Dev Med Child Neurol 11:384CrossRefPubMedGoogle Scholar
  37. 37.
    Nordmark E, Jarnlo GB, Hägglund G (2000) Comparison of the gross motor function measure and paediatric evaluation of disability inventory in assessing motor function in children undergoing selective dorsal rhizotomy. Dev Med Child Neurol 42:245–252CrossRefPubMedGoogle Scholar
  38. 38.
    Nordmark E, Josenby AL, Lagergren J, Andersson G, Stromblad LG, Westbom L (2008) Long-term outcomes five years after selective dorsal rhizotomy. BMC Pediatr 8:54CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N et al (2013) A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol 55(10):885–910CrossRefPubMedGoogle Scholar
  40. 40.
    Palisano R, Rosenbaum P, Walter S et al (1997) Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 39:214–223CrossRefPubMedGoogle Scholar
  41. 41.
    Park TS, Johnston JM (2006) Surgical techniques of selective dorsal rhizotomy for spastic cerebral palsy. Technical note. Neurosurg Focus 21(2):E7PubMedGoogle Scholar
  42. 42.
    Park TS, Gaffney PE, Kaufman BA, Molleston MC (1993) Selective lumbosacral dorsal rhizotomy immediately caudal to the conus medullaris for cerebral palsy spasticity. Neurosurgery 33:929–933PubMedGoogle Scholar
  43. 43.
    Park TS, Vogler GP, Phillips LH 2nd, Kaufman BA, Ortman MR, McClure SM et al (1994) Effects of selective dorsal rhizotomy for spastic diplegia on hip migration in cerebral palsy. Pediatr Neurosurg 20:43–49CrossRefPubMedGoogle Scholar
  44. 44.
    Peacock WJ, Arens LJ (1982) Selective posterior rhizotomy for the relief of spasticity in cerebral palsy. S Afr Med J 62:119–124PubMedGoogle Scholar
  45. 45.
    Peacock WJ, Arens LJ, Berman B (1987) Cerebral palsy spasticity. Selective posterior rhizotomy. Pediatr Neurosci 13:61–66CrossRefPubMedGoogle Scholar
  46. 46.
    Pinder C, Bhakta B, Kodavali K (2008) Intrathecal phenol: an old treatment revisited. Disabil Rehabil 30(5):381–386CrossRefPubMedGoogle Scholar
  47. 47.
    Rosenbaum PL, Walter SD, Hanna SE et al (2002) Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA 288:1357–1363CrossRefPubMedGoogle Scholar
  48. 48.
    Spiegel DA, Loder RT, Alley KA et al (2004) Spinal deformity following selective dorsal rhizotomy. J Pediatr Orthop 24:30–36CrossRefPubMedGoogle Scholar
  49. 49.
    Steinbok P (2001) Outcomes after selective dorsal rhizotomy for spastic cerebral palsy. Childs Nerv Syst 17(1–2):1–18CrossRefPubMedGoogle Scholar
  50. 50.
    Steinbok P (2007) Selective dorsal rhizotomy for spastic cerebral palsy: a review. Childs Nerv Syst 23:981–990CrossRefPubMedGoogle Scholar
  51. 51.
    Steinbok P, Schrag C (1998) Complications after selective posterior rhizotomy for spasticity in children with cerebral palsy. Pediatr Neurosurg 28:300–313CrossRefPubMedGoogle Scholar
  52. 52.
    Steinbok P, Renier AM, Beachamp R, Armstrong RW, Chochrane DD, Kestle J (1997) A randomized controlled trial to compare selective dorsal rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy. Dev Med Child Neurol 39:178–184CrossRefPubMedGoogle Scholar
  53. 53.
    Steinbok P, Tidemann AJ, Miller S, Mortenson P, Bowen-Roberts T (2009) Electrophysiologically guided versus non-electrophysiologically guided selective dorsal rhizotomy for spastic cerebral palsy: a comparison of outcomes. Childs Nerv Syst 25(9):1091–1096CrossRefPubMedGoogle Scholar
  54. 54.
    Tan TC, Black PM (2001) The contributions of Otfrid Foerster (1873-1941) to neurology and neurosurgery. Neurosurgery 49:1231–1235PubMedGoogle Scholar
  55. 55.
    Tedroff K, Löwing K, Åström E (2015) A prospective cohort study investigating gross motor function, pain, and health-related quality of life 17 years after selective dorsal rhizotomy in cerebral palsy. Dev Med Child Neurol 57:484–490CrossRefPubMedGoogle Scholar
  56. 56.
    Turi M, Kalen V (2000) The risk of spinal deformity after selective dorsal rhizotomy. J Pediatr Orthop 20:104–107PubMedGoogle Scholar
  57. 57.
    Van Schie PE, Schothorst M, Dallmeijer AJ, Vermeulen RJ, van Ouwerkerk WJ, Strijers RL, Becher JG (2011) Short- and long-term effects of selective dorsal rhizotomy on gross motor function in ambulatory children with spastic diplegia. J Neurosurg Pediatr 7(5):557–562CrossRefPubMedGoogle Scholar
  58. 58.
    Vaughan CL, Berman B, Peacock WJ (1991) Cerebral palsy and rhizotomy. A 3-year follow-up evaluation with gait analysis. J Neurosurg 74:178–184CrossRefPubMedGoogle Scholar
  59. 59.
    Vender JR, Hester S, Waller JL, Rekito A, Lee MR (2006) Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg 104(1 Suppl):9–15PubMedGoogle Scholar
  60. 60.
    Wright FV, Sheil EM, Drake JM, Wedge JH, Naumann S (1998) Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Dev Med Child Neurol 40:239–247CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria 2017

Authors and Affiliations

  1. 1.Department of NeurosurgeryQueen’s Medical CentreNottinghamUK
  2. 2.Department of NeurosurgeryQueen Elizabeth HospitalBirminghamUK

Personalised recommendations